Skip to main content
If you continue browsing this website, you agree to our policies:
  • Terms and Conditions
  • Privacy & Cookies Policy
Continue
x
  • Home
  • About
    About Open Classroom EUPATI Fellows Our Impact FAQ
  • Open Classroom
    Learning Catalogue Patient Expert Training Programme
  • Resources
    Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources Patient Education Compass
  • EUPATI website
  • More
English ‎(en_wp)‎
Čeština ‎(cs)‎ Deutsch ‎(de_wp)‎ English ‎(en_wp)‎ Español ‎(es_wp)‎ Français ‎(fr_wp)‎ Italiano ‎(it_wp)‎ Nederlands ‎(nl_wp)‎ Português - Portugal ‎(pt)‎ Ελληνικά ‎(el_wp)‎
Log in

    Side Drawer

    EUPATI Open Classroom
    Profile Home About Collapse Expand
    About Open Classroom EUPATI Fellows Our Impact FAQ
    Open Classroom Collapse Expand
    Learning Catalogue Patient Expert Training Programme
    Resources Collapse Expand
    Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources Patient Education Compass
    EUPATI website

    Glossary

    Back

    Thalidomide

    Thalidomide is a medicine that was developed in the 1950s as a sedative. It was used later against nausea in pregnant women, but this resulted in the birth of about 10,000 infants with deformed limbs, and sometimes with other serious problems such as blindness, deafness, and heart problems. More than half of these children died. This crisis led to more structured regulations for the development and use of medicines. Currently, thalidomide is used to treat certain cancers, and to alleviate symptoms of leprosy.

    » Glossary

    Previous Activity
    Next Activity

    Footer

    You are not logged in. (Log in)
    Policies
    Get the mobile app
    Powered by Moodle

    About EUPATI

    • About Open Classroom
    • FAQ
    • Contact us

    Start learning

    • Learning Catalogue
    • Patient Expert Training Programme

    Resources

    • EUPATI Toolbox
    • Patient Involvement Roadmap
    • Accessibility Resources

    Terms of Use & Privacy

    • Terms and Conditions
    • Privacy and Cookie Policy

    The EUPATI Open Classroom was initially launched with support from the EUPATI Reload project, funded by EIT Health. EIT Health is supported by EIT, a body of the European Union. 

    For more information about EUPATI, please access our website www.eupati.eu or contact us at openclassroom@eupati.eu

    EIT Health logo and EU logo

    © 2025 EUPATI

    • https://eupati.eu/
    • https://www.linkedin.com/company/15178871/admin/dashboard/
    • https://www.youtube.com/user/PatientsAcademy
    • https://www.instagram.com/eupatients/
    • https://www.facebook.com/eupati.eu/
    Select banner image